PROPOFOL

PROPOFOL was reported 37019 times

These side effects are most commonly reported by patients taking PROPOFOL:

# Side effect Count
0 HYPOTENSION 2992
1 DRUG INEFFECTIVE 2858
2 ANAPHYLACTIC SHOCK 2182
3 CARDIAC ARREST 1851
4 ANAPHYLACTIC REACTION 1762
5 OFF LABEL USE 1736
6 DRUG INTERACTION 1583
7 TACHYCARDIA 1234
8 BRADYCARDIA 1212
9 ACUTE KIDNEY INJURY 1024
10 PYREXIA 1024
11 RHABDOMYOLYSIS 932
12 BRONCHOSPASM 833
13 OXYGEN SATURATION DECREASED 820
14 RENAL FAILURE 820
15 TOXICITY TO VARIOUS AGENTS 786
16 RESPIRATORY FAILURE 752
17 PAIN 747
18 SEROTONIN SYNDROME 742
19 RASH 722
20 NAUSEA 713
21 VOMITING 704
22 DYSPNOEA 697
23 HYPOXIA 687
24 METABOLIC ACIDOSIS 648
25 CONDITION AGGRAVATED 633
26 BLOOD PRESSURE DECREASED 630
27 PROPOFOL INFUSION SYNDROME 626
28 PRODUCT USE IN UNAPPROVED INDICATION 605
29 ERYTHEMA 584
30 PNEUMONIA 580
31 HYPERTENSION 570
32 AGITATION 554
33 STATUS EPILEPTICUS 548
34 SEPSIS 539
35 ANXIETY 530
36 DEATH 530
37 CIRCULATORY COLLAPSE 529
38 OVERDOSE 525
39 RENAL IMPAIRMENT 519
40 URTICARIA 497
41 MATERNAL EXPOSURE DURING PREGNANCY 483
42 FOETAL EXPOSURE DURING PREGNANCY 470
43 SEIZURE 465
44 THROMBOCYTOPENIA 453
45 CARDIO-RESPIRATORY ARREST 437
46 RESPIRATORY DEPRESSION 437
47 ATRIAL FIBRILLATION 435
48 INJURY 424
49 SHOCK 424
50 MULTIPLE ORGAN DYSFUNCTION SYNDROME 423
51 DRUG HYPERSENSITIVITY 420
52 SOMNOLENCE 419
53 CHILLS 418
54 BLOOD CREATINE PHOSPHOKINASE INCREASED 417
55 HYPERTHERMIA MALIGNANT 416
56 RENAL FAILURE ACUTE 410
57 VENTRICULAR TACHYCARDIA 405
58 HYPERKALAEMIA 395
59 SEPTIC SHOCK 390
60 VENTRICULAR FIBRILLATION 379
61 ALANINE AMINOTRANSFERASE INCREASED 376
62 POST PROCEDURAL COMPLICATION 373
63 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 372
64 ASTHENIA 366
65 CONFUSIONAL STATE 366
66 ELECTROCARDIOGRAM QT PROLONGED 365
67 HAEMODYNAMIC INSTABILITY 362
68 PULMONARY OEDEMA 361
69 DEPRESSED LEVEL OF CONSCIOUSNESS 357
70 MULTI-ORGAN FAILURE 353
71 LOSS OF CONSCIOUSNESS 350
72 HYPERSENSITIVITY 346
73 HEADACHE 345
74 COMA 344
75 ANAEMIA 339
76 DIARRHOEA 339
77 RESPIRATORY ARREST 339
78 COUGH 327
79 EMOTIONAL DISTRESS 327
80 DELAYED RECOVERY FROM ANAESTHESIA 326
81 EXPOSURE DURING PREGNANCY 323
82 MYOCLONUS 323
83 UNEVALUABLE EVENT 320
84 UNRESPONSIVE TO STIMULI 315
85 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 310
86 DELIRIUM 306
87 PREMATURE BABY 292
88 ASPARTATE AMINOTRANSFERASE INCREASED 290
89 STRESS CARDIOMYOPATHY 287
90 DIZZINESS 283
91 TOXIC EPIDERMAL NECROLYSIS 279
92 ACUTE RESPIRATORY DISTRESS SYNDROME 277
93 ANGIOEDEMA 276
94 FATIGUE 276
95 FEAR 272
96 ENCEPHALOPATHY 269
97 HEART RATE INCREASED 268
98 ABDOMINAL PAIN 260
99 BLOOD CREATININE INCREASED 256
100 BLOOD PRESSURE INCREASED 254
101 DYSKINESIA 252
102 LACTIC ACIDOSIS 249
103 HEPATIC FAILURE 248
104 ARRHYTHMIA 246
105 PRURITUS 245
106 CARDIAC FAILURE 243
107 COAGULOPATHY 242
108 HYPERHIDROSIS 241
109 RENAL INJURY 241
110 DYSTONIA 240
111 RESPIRATORY DISTRESS 240
112 TREMOR 238
113 BACK PAIN 237
114 APNOEA 236
115 RESPIRATORY ACIDOSIS 235
116 HAEMORRHAGE 234
117 DEPRESSION 232
118 PLEURAL EFFUSION 229
119 PULSELESS ELECTRICAL ACTIVITY 229
120 CONVULSION 228
121 GENERALISED TONIC-CLONIC SEIZURE 228
122 PULMONARY EMBOLISM 228
123 CARDIOGENIC SHOCK 223
124 HYPOKALAEMIA 223
125 ANAESTHETIC COMPLICATION 221
126 GENERAL PHYSICAL HEALTH DETERIORATION 221
127 SINUS TACHYCARDIA 219
128 BRAIN OEDEMA 216
129 MEDICATION ERROR 215
130 MALAISE 214
131 TACHYPNOEA 213
132 ACUTE RESPIRATORY FAILURE 212
133 TORSADE DE POINTES 210
134 PNEUMONIA ASPIRATION 208
135 RASH MACULO-PAPULAR 208
136 COMPLETED SUICIDE 207
137 MUSCULAR WEAKNESS 206
138 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 205
139 ANAESTHETIC COMPLICATION NEUROLOGICAL 203
140 STRESS 201
141 ANHEDONIA 200
142 GASTROINTESTINAL HAEMORRHAGE 196
143 DISSEMINATED INTRAVASCULAR COAGULATION 191
144 HAEMOGLOBIN DECREASED 190
145 DIABETES INSIPIDUS 189
146 MYOCARDIAL INFARCTION 189
147 CHEST PAIN 188
148 DYSPHAGIA 187
149 MYALGIA 185
150 DRUG ABUSE 184
151 HEPATITIS 183
152 PROCEDURAL COMPLICATION 183
153 HYPERTRIGLYCERIDAEMIA 181
154 CYANOSIS 180
155 MULTIPLE-DRUG RESISTANCE 176
156 WEIGHT DECREASED 176
157 ABDOMINAL DISTENSION 175
158 CEREBROVASCULAR ACCIDENT 173
159 HEART RATE DECREASED 172
160 MUSCLE RIGIDITY 172
161 INTESTINAL ISCHAEMIA 171
162 PANCREATITIS 170
163 FALL 168
164 PANCREATITIS ACUTE 168
165 PREMATURE DELIVERY 168
166 LARYNGOSPASM 167
167 HEPATOCELLULAR INJURY 166
168 INTENTIONAL OVERDOSE 165
169 LEUKOCYTOSIS 165
170 PRODUCT USE ISSUE 165
171 HEPATIC FUNCTION ABNORMAL 164
172 INFECTION 164
173 URINARY TRACT INFECTION 164
174 FLUSHING 163
175 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 162
176 MYDRIASIS 162
177 NEUTROPENIA 161
178 PLATELET COUNT DECREASED 161
179 ACUTE HEPATIC FAILURE 160
180 DEEP VEIN THROMBOSIS 160
181 EOSINOPHILIA 160
182 VENTRICULAR EXTRASYSTOLES 156
183 CHRONIC KIDNEY DISEASE 155
184 WHEEZING 155
185 ATELECTASIS 154
186 BLOOD BILIRUBIN INCREASED 154
187 CHOLESTASIS 153
188 ARTERIOSPASM CORONARY 152
189 PRODUCT QUALITY ISSUE 152
190 CONSTIPATION 151
191 INSOMNIA 151
192 OEDEMA PERIPHERAL 151
193 SINUS BRADYCARDIA 151
194 DEHYDRATION 150
195 RASH ERYTHEMATOUS 150
196 DISORIENTATION 149
197 PAIN IN EXTREMITY 149
198 HYPOVENTILATION 148
199 NEUROLEPTIC MALIGNANT SYNDROME 148
200 DRUG-INDUCED LIVER INJURY 146
201 STEVENS-JOHNSON SYNDROME 146
202 TREATMENT FAILURE 146
203 DRUG WITHDRAWAL SYNDROME 145
204 MENTAL STATUS CHANGES 145
205 NO ADVERSE EVENT 144
206 ALTERED STATE OF CONSCIOUSNESS 143
207 NEUROMUSCULAR BLOCK PROLONGED 143
208 BLOOD LACTATE DEHYDROGENASE INCREASED 142
209 HYPERCAPNIA 142
210 SUICIDE ATTEMPT 142
211 THERAPY NON-RESPONDER 142
212 ACIDOSIS 141
213 PNEUMOTHORAX 141
214 PROCEDURAL HYPOTENSION 140
215 HEPATIC CYTOLYSIS 139
216 EPILEPSY 138
217 GAIT DISTURBANCE 138
218 PARAESTHESIA 138
219 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 138
220 RESPIRATORY DISORDER 137
221 SHOCK HAEMORRHAGIC 137
222 ARTHRALGIA 136
223 GENERALISED ERYTHEMA 136
224 DRUG EFFECT DECREASED 135
225 FACE OEDEMA 134
226 ATRIOVENTRICULAR BLOCK COMPLETE 133
227 COGNITIVE DISORDER 132
228 MUSCLE SPASMS 132
229 AGGRESSION 130
230 CEREBRAL HAEMORRHAGE 128
231 OEDEMA 127
232 HYPERTHERMIA 125
233 ACUTE PULMONARY OEDEMA 124
234 HYPERGLYCAEMIA 124
235 HYPOAESTHESIA 124
236 HYPONATRAEMIA 124
237 PULSE ABSENT 124
238 TRANSAMINASES INCREASED 124
239 OLIGURIA 123
240 ABDOMINAL PAIN UPPER 121
241 JAUNDICE 121
242 HEPATIC ENZYME INCREASED 120
243 ASCITES 119
244 BLOOD LACTIC ACID INCREASED 119
245 DECREASED APPETITE 118
246 PARTIAL SEIZURES 118
247 TROPONIN INCREASED 118
248 HYPOTHERMIA 117
249 THERAPEUTIC PRODUCT EFFECT DECREASED 117
250 CHROMATURIA 116
251 HAEMATURIA 116
252 PANCYTOPENIA 116
253 SEDATION 116
254 RESTLESSNESS 115
255 CLONUS 114
256 LIVER INJURY 114
257 SUPRAVENTRICULAR TACHYCARDIA 114
258 SYNCOPE 114
259 ACUTE MYOCARDIAL INFARCTION 113
260 HEPATITIS C 113
261 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 112
262 PULMONARY ALVEOLAR HAEMORRHAGE 112
263 RENAL TUBULAR NECROSIS 111
264 HAEMATEMESIS 109
265 KOUNIS SYNDROME 109
266 DYSARTHRIA 108
267 INTENTIONAL PRODUCT MISUSE 108
268 MEMORY IMPAIRMENT 108
269 ANAPHYLACTOID REACTION 107
270 HYPOVOLAEMIA 107
271 LIVER DISORDER 107
272 BODY TEMPERATURE INCREASED 106
273 CARDIOVASCULAR DISORDER 106
274 LARYNGEAL OEDEMA 106
275 POST PROCEDURAL HAEMORRHAGE 106
276 FEBRILE NEUTROPENIA 105
277 HAEMOPTYSIS 105
278 OBSTRUCTIVE AIRWAYS DISORDER 105
279 STRIDOR 105
280 TOXIC ENCEPHALOPATHY 105
281 TYPE I HYPERSENSITIVITY 105
282 BLOOD POTASSIUM INCREASED 104
283 BRAIN INJURY 104
284 CARDIAC FAILURE CONGESTIVE 104
285 HAEMODIALYSIS 104
286 MYOCARDIAL ISCHAEMIA 104
287 PARALYSIS 104
288 GASTROOESOPHAGEAL REFLUX DISEASE 103
289 SPEECH DISORDER 102
290 WHITE BLOOD CELL COUNT INCREASED 102
291 ASPIRATION 101
292 DRUG RESISTANCE 101
293 HALLUCINATION 101
294 ILEUS 101
295 LEUKOPENIA 101
296 SWELLING FACE 101
297 APHASIA 100
298 EPISTAXIS 100
299 ACCIDENTAL OVERDOSE 99
300 ANURIA 99
301 HYPERBILIRUBINAEMIA 99
302 LIVER FUNCTION TEST ABNORMAL 99
303 VASOPLEGIA SYNDROME 99
304 AMNESIA 98
305 BLOOD TRIGLYCERIDES INCREASED 98
306 PALLOR 98
307 ATRIOVENTRICULAR BLOCK 97
308 BLOOD ALKALINE PHOSPHATASE INCREASED 97
309 NEUROTOXICITY 97
310 SWOLLEN TONGUE 96
311 DRUG DEPENDENCE 95
312 HEPATOTOXICITY 95
313 MUSCLE TWITCHING 95
314 INCORRECT DOSE ADMINISTERED 94
315 LEFT VENTRICULAR DYSFUNCTION 94
316 CARDIAC DISORDER 93
317 ELECTROENCEPHALOGRAM ABNORMAL 93
318 OROPHARYNGEAL PAIN 93
319 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 92
320 NERVOUS SYSTEM DISORDER 92
321 CHEST DISCOMFORT 91
322 HYPERTENSIVE CRISIS 91
323 COVID-19 90
324 POLYURIA 90
325 CEREBRAL INFARCTION 89
326 HEPATITIS ACUTE 89
327 INTENTIONAL PRODUCT USE ISSUE 89
328 AIRWAY COMPLICATION OF ANAESTHESIA 88
329 C-REACTIVE PROTEIN INCREASED 88
330 INTERSTITIAL LUNG DISEASE 88
331 HYPERNATRAEMIA 87
332 HYPOGLYCAEMIA 86
333 HYPOTONIA 86
334 URINARY RETENTION 86
335 VENTRICULAR ARRHYTHMIA 86
336 PRODUCT CONTAMINATION 85
337 VISION BLURRED 85
338 WITHDRAWAL SYNDROME 84
339 OSTEOARTHRITIS 83
340 STAPHYLOCOCCAL INFECTION 83
341 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 82
342 MOTOR DYSFUNCTION 82
343 PULMONARY HYPERTENSION 82
344 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 82
345 UNWANTED AWARENESS DURING ANAESTHESIA 82
346 EXTRAPYRAMIDAL DISORDER 81
347 HYPERREFLEXIA 81
348 PRODUCT CONTAMINATION MICROBIAL 81
349 SEDATION COMPLICATION 81
350 AGRANULOCYTOSIS 80
351 BLOOD GLUCOSE INCREASED 80
352 GAMMA-GLUTAMYLTRANSFERASE INCREASED 80
353 GRAND MAL CONVULSION 80
354 LETHARGY 80
355 MATERNAL EXPOSURE DURING DELIVERY 80
356 RASH GENERALISED 80
357 ASTHMA 79
358 DRUG LEVEL INCREASED 79
359 LIP SWELLING 79
360 MOVEMENT DISORDER 79
361 CELLULITIS 78
362 CONTRAINDICATED PRODUCT ADMINISTERED 78
363 FEELING ABNORMAL 78
364 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 78
365 AMYLASE INCREASED 77
366 CARDIOMYOPATHY 77
367 FOETAL DEATH 77
368 LIVER FUNCTION TEST INCREASED 77
369 LOW BIRTH WEIGHT BABY 77
370 TREATMENT NONCOMPLIANCE 77
371 URINARY INCONTINENCE 77
372 CARDIOMEGALY 76
373 COVID-19 PNEUMONIA 76
374 EJECTION FRACTION DECREASED 76
375 ENDOTRACHEAL INTUBATION 76
376 INFLAMMATION 76
377 PALPITATIONS 76
378 THROMBOSIS 75
379 PROCEDURAL PAIN 74
380 VENTRICULAR HYPOKINESIA 74
381 WEIGHT INCREASED 74
382 BLOOD CALCIUM DECREASED 73
383 HAEMATOMA 73
384 BLISTER 72
385 DRUG TOXICITY 72
386 HYPERLIPIDAEMIA 72
387 INTERNATIONAL NORMALISED RATIO INCREASED 72
388 MYOGLOBIN URINE PRESENT 72
389 NYSTAGMUS 72
390 SWELLING 72
391 VISUAL IMPAIRMENT 72
392 ANTICHOLINERGIC SYNDROME 71
393 HYPERAMMONAEMIA 71
394 LABILE BLOOD PRESSURE 71
395 LUNG DISORDER 71
396 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 71
397 TRYPTASE INCREASED 71
398 BRAIN HERNIATION 70
399 DIALYSIS 70
400 DISEASE PROGRESSION 70
401 END STAGE RENAL DISEASE 70
402 THERAPEUTIC RESPONSE DECREASED 70
403 WHITE BLOOD CELL COUNT DECREASED 70
404 EXTRAVASATION 69
405 LUNG INFILTRATION 69
406 CORONARY ARTERY DISEASE 68
407 HYPOMAGNESAEMIA 68
408 MUSCULOSKELETAL STIFFNESS 68
409 NO THERAPEUTIC RESPONSE 68
410 SEIZURE LIKE PHENOMENA 68
411 TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 68
412 BRAIN DEATH 67
413 DIABETES MELLITUS 67
414 HEPARIN-INDUCED THROMBOCYTOPENIA 67
415 NEGATIVE PRESSURE PULMONARY OEDEMA 67
416 URINE OUTPUT DECREASED 67
417 BLOOD UREA INCREASED 65
418 SLEEP DISORDER 65
419 AUTONOMIC NERVOUS SYSTEM IMBALANCE 64
420 MITRAL VALVE INCOMPETENCE 64
421 RESUSCITATION 64
422 SINUS ARREST 64
423 DRUG USE DISORDER 63
424 HYPOCALCAEMIA 63
425 TUBULOINTERSTITIAL NEPHRITIS 63
426 WRONG TECHNIQUE IN DRUG USAGE PROCESS 63
427 CHOLELITHIASIS 62
428 FLATULENCE 62
429 PERIORBITAL OEDEMA 62
430 SALIVARY HYPERSECRETION 62
431 THROMBOTIC MICROANGIOPATHY 62
432 CYTOKINE RELEASE SYNDROME 61
433 DRUG ERUPTION 61
434 ELECTROCARDIOGRAM ABNORMAL 61
435 NEPHROGENIC ANAEMIA 61
436 PRIAPISM 61
437 PSEUDOMONAS INFECTION 61
438 PSYCHOTIC DISORDER 61
439 PULMONARY CONGESTION 61
440 TOXIC SKIN ERUPTION 61
441 BACTERAEMIA 60
442 POSTOPERATIVE DELIRIUM 60
443 SUBARACHNOID HAEMORRHAGE 60
444 ATAXIA 59
445 HEPATIC STEATOSIS 59
446 HYPERLACTACIDAEMIA 59
447 HYPOALBUMINAEMIA 59
448 ISCHAEMIC CEREBRAL INFARCTION 59
449 KLEBSIELLA INFECTION 59
450 SKIN TEST POSITIVE 59
451 BLOOD ALBUMIN DECREASED 58
452 CAESAREAN SECTION 58
453 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 58
454 MIGRAINE 58
455 PCO2 INCREASED 58
456 TRIGEMINO-CARDIAC REFLEX 58
457 ULCER 58
458 BLOOD PH DECREASED 57
459 DRUG EXPOSURE DURING PREGNANCY 57
460 FLUID OVERLOAD 57
461 PSYCHOMOTOR HYPERACTIVITY 57
462 ANAPHYLACTOID SHOCK 56
463 BLOOD POTASSIUM DECREASED 56
464 BLOOD PRESSURE SYSTOLIC DECREASED 56
465 INFLUENZA LIKE ILLNESS 56
466 NECROSIS ISCHAEMIC 56
467 METHAEMOGLOBINAEMIA 55
468 PERIPHERAL SWELLING 55
469 RASH MACULAR 55
470 CARDIAC FAILURE ACUTE 54
471 DIPLOPIA 54
472 ENCEPHALITIS 54
473 IRRITABILITY 54
474 ABDOMINAL DISCOMFORT 53
475 AREFLEXIA 53
476 CEREBRAL ISCHAEMIA 53
477 DRUG ADMINISTRATION ERROR 53
478 INTRACRANIAL PRESSURE INCREASED 53
479 MENTAL DISORDER 53
480 MOBILITY DECREASED 53
481 BRUGADA SYNDROME 52
482 CARDIOTOXICITY 52
483 DRUG LEVEL BELOW THERAPEUTIC 52
484 ELECTROLYTE IMBALANCE 52
485 EXTRASYSTOLES 52
486 FEELING HOT 52
487 HAEMATOCRIT DECREASED 52
488 HEMIPARESIS 52
489 HYPOTHYROIDISM 52
490 HYPOVOLAEMIC SHOCK 52
491 NEUROPATHY PERIPHERAL 52
492 NON-CARDIOGENIC PULMONARY OEDEMA 52
493 NORMAL NEWBORN 52
494 TINNITUS 52
495 AIRWAY PEAK PRESSURE INCREASED 51
496 CLOSTRIDIUM DIFFICILE COLITIS 51
497 COLITIS 51
498 DISTURBANCE IN ATTENTION 51
499 DYSPEPSIA 51
500 EYELID OEDEMA 51
501 HYPERTRANSAMINASAEMIA 51
502 LEFT VENTRICULAR HYPERTROPHY 51
503 MIXED LIVER INJURY 51
504 OPISTHOTONUS 51
505 PARADOXICAL DRUG REACTION 51
506 RECTAL HAEMORRHAGE 51
507 SUPRAVENTRICULAR EXTRASYSTOLES 51
508 BALANCE DISORDER 50
509 BLOOD MAGNESIUM DECREASED 50
510 INCREASED BRONCHIAL SECRETION 50
511 METABOLIC DISORDER 50
512 OCULOGYRIC CRISIS 50
513 PERICARDIAL EFFUSION 50
514 SPINAL OSTEOARTHRITIS 50
515 TRISMUS 50
516 ABNORMAL BEHAVIOUR 49
517 ATRIOVENTRICULAR BLOCK FIRST DEGREE 49
518 DISCOMFORT 49
519 DYSURIA 49
520 GASTROINTESTINAL DISORDER 49
521 HAEMORRHOIDS 49
522 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 49
523 INTESTINAL PERFORATION 49
524 MYOCARDITIS 49
525 RASH PRURITIC 49
526 UPPER AIRWAY OBSTRUCTION 49
527 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 48
528 BLOOD PRESSURE SYSTOLIC INCREASED 48
529 BUNDLE BRANCH BLOCK RIGHT 48
530 ELECTROMECHANICAL DISSOCIATION 48
531 GENERALISED OEDEMA 48
532 HEPATIC CIRRHOSIS 48
533 HYPERTONIA 48
534 INFUSION RELATED REACTION 48
535 PROCEDURAL HAEMORRHAGE 48
536 PRODUCT DOSE OMISSION ISSUE 48
537 SCOLIOSIS 48
538 TACHYARRHYTHMIA 48
539 ATRIOVENTRICULAR BLOCK SECOND DEGREE 47
540 CYTOLYTIC HEPATITIS 47
541 DYSPNOEA EXERTIONAL 47
542 HEPATORENAL SYNDROME 47
543 MENTAL IMPAIRMENT 47
544 PATENT DUCTUS ARTERIOSUS 47
545 RENAL DISORDER 47
546 RHINORRHOEA 47
547 TRICUSPID VALVE INCOMPETENCE 47
548 VENTRICULAR DYSFUNCTION 47
549 BLOOD PRESSURE FLUCTUATION 46
550 BLOOD PRESSURE IMMEASURABLE 46
551 BRADYARRHYTHMIA 46
552 DERMATITIS ALLERGIC 46
553 DERMATITIS BULLOUS 46
554 DRUG INTOLERANCE 46
555 DYSPHONIA 46
556 MYOCLONIC EPILEPSY 46
557 NEUROMUSCULAR BLOCKADE 46
558 OXYGEN SATURATION ABNORMAL 46
559 PNEUMONIA BACTERIAL 46
560 BUNDLE BRANCH BLOCK LEFT 45
561 DIVERTICULITIS 45
562 DUODENAL ULCER 45
563 EYE MOVEMENT DISORDER 45
564 HEPATITIS FULMINANT 45
565 HYPERVENTILATION 45
566 INCORRECT ROUTE OF DRUG ADMINISTRATION 45
567 LONG QT SYNDROME 45
568 PULMONARY HAEMORRHAGE 45
569 SLEEP APNOEA SYNDROME 45
570 UPPER GASTROINTESTINAL HAEMORRHAGE 45
571 ABSCESS 44
572 BRADYCARDIA FOETAL 44
573 GASTRITIS 44
574 HEPATIC ENCEPHALOPATHY 44
575 HEPATOMEGALY 44
576 INJECTION SITE PAIN 44
577 PRODUCTIVE COUGH 44
578 TONIC CLONIC MOVEMENTS 44
579 BRONCHITIS 43
580 DISEASE RECURRENCE 43
581 HYPOPHOSPHATAEMIA 43
582 LYMPHOPENIA 43
583 MALNUTRITION 43
584 PNEUMONITIS 43
585 REBOUND EFFECT 43
586 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 43
587 CHEST X-RAY ABNORMAL 42
588 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 42
589 LYMPHADENOPATHY 42
590 MECHANICAL VENTILATION 42
591 MELAENA 42
592 NEPHROGENIC DIABETES INSIPIDUS 42
593 NEUROLOGICAL DECOMPENSATION 42
594 QUALITY OF LIFE DECREASED 42
595 RALES 42
596 RECURRENCE OF NEUROMUSCULAR BLOCKADE 42
597 RESPIRATORY RATE DECREASED 42
598 ADVERSE DRUG REACTION 41
599 BLOOD BICARBONATE DECREASED 41
600 BURNING SENSATION 41
601 CONTUSION 41
602 EMPHYSEMA 41
603 ENDOTRACHEAL INTUBATION COMPLICATION 41
604 FUNGAL INFECTION 41
605 INFLUENZA 41
606 MECHANICAL VENTILATION COMPLICATION 41
607 NECK PAIN 41
608 TONGUE OEDEMA 41
609 ALLERGY TEST NEGATIVE 40
610 CATATONIA 40
611 HAEMOTHORAX 40
612 HEPATITIS CHOLESTATIC 40
613 HIATUS HERNIA 40
614 INCORRECT DRUG ADMINISTRATION RATE 40
615 LUNG CONSOLIDATION 40
616 MOOD SWINGS 40
617 NECROSIS 40
618 NECROTISING FASCIITIS 40
619 PRODUCT SUBSTITUTION ISSUE 40
620 RASH MORBILLIFORM 40
621 RENAL ISCHAEMIA 40
622 ABORTION INDUCED 39
623 CARDIOVASCULAR INSUFFICIENCY 39
624 DEAFNESS NEUROSENSORY 39
625 GAZE PALSY 39
626 NEW ONSET REFRACTORY STATUS EPILEPTICUS 39
627 PARAPLEGIA 39
628 POISONING 39
629 PROCEDURAL NAUSEA 39
630 PROCEDURAL VOMITING 39
631 RHEUMATOID ARTHRITIS 39
632 SKIN DISCOLOURATION 39
633 TORTICOLLIS 39
634 ADRENAL INSUFFICIENCY 38
635 ATRIAL FLUTTER 38
636 DEVICE ISSUE 38
637 GASTRIC ULCER 38
638 HAEMATOCHEZIA 38
639 HAEMORRHAGE INTRACRANIAL 38
640 HYPOKINESIA 38
641 ISCHAEMIC STROKE 38
642 MIOSIS 38
643 MITOCHONDRIAL DNA MUTATION 38
644 NEUTROPHIL COUNT DECREASED 38
645 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 38
646 APGAR SCORE LOW 37
647 ARTERIOSCLEROSIS CORONARY ARTERY 37
648 BLOOD GASES ABNORMAL 37
649 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 37
650 DISABILITY 37
651 GENE MUTATION 37
652 ILL-DEFINED DISORDER 37
653 LIMB DISCOMFORT 37
654 MYOCARDIAL DEPRESSION 37
655 PO2 INCREASED 37
656 PROTHROMBIN TIME PROLONGED 37
657 RETCHING 37
658 SUBCUTANEOUS EMPHYSEMA 37
659 SUICIDAL IDEATION 37
660 ACUTE CORONARY SYNDROME 36
661 ERYTHEMA MULTIFORME 36
662 HALLUCINATION, VISUAL 36
663 HEPATIC ISCHAEMIA 36
664 HORNER^S SYNDROME 36
665 INTRA-ABDOMINAL HAEMORRHAGE 36
666 LIPASE INCREASED 36
667 MUSCLE SPASTICITY 36
668 NASOPHARYNGITIS 36
669 NODAL RHYTHM 36
670 POTENTIATING DRUG INTERACTION 36
671 SUSPECTED PRODUCT CONTAMINATION 36
672 ALOPECIA 35
673 COMA SCALE ABNORMAL 35
674 ELECTROCARDIOGRAM T WAVE INVERSION 35
675 HYPERCHOLESTEROLAEMIA 35
676 HYPERVOLAEMIA 35
677 INFUSION SITE EXTRAVASATION 35
678 LIP OEDEMA 35
679 MUSCULOSKELETAL PAIN 35
680 PERITONITIS 35
681 POLYNEUROPATHY 35
682 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 35
683 RASH PAPULAR 35
684 RESPIRATORY RATE INCREASED 35
685 TRANSIENT ISCHAEMIC ATTACK 35
686 WRONG PRODUCT ADMINISTERED 35
687 AKATHISIA 34
688 ANGIOPATHY 34
689 CARDIAC OUTPUT DECREASED 34
690 CATARACT 34
691 COLITIS ISCHAEMIC 34
692 FOETAL GROWTH RESTRICTION 34
693 FOURNIER^S GANGRENE 34
694 HAEMOLYSIS 34
695 HAEMOLYTIC ANAEMIA 34
696 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 34
697 MYOGLOBIN BLOOD INCREASED 34
698 SINUSITIS 34
699 SKIN EXFOLIATION 34
700 SNEEZING 34
701 UPPER RESPIRATORY TRACT INFECTION 34
702 ABDOMINAL RIGIDITY 33
703 ACIDOSIS HYPERCHLORAEMIC 33
704 ARTERIOSCLEROSIS 33
705 HEPATOCELLULAR DAMAGE 33
706 HYPERAMMONAEMIC ENCEPHALOPATHY 33
707 HYPERCALCAEMIA 33
708 MUSCLE ATROPHY 33
709 MYOPATHY 33
710 NERVOUSNESS 33
711 PANCREATITIS NECROTISING 33
712 PROTEINURIA 33
713 SPUTUM INCREASED 33
714 CARDIOPULMONARY FAILURE 32
715 CHRONIC GASTRITIS 32
716 CLOSTRIDIUM DIFFICILE INFECTION 32
717 DISEASE COMPLICATION 32
718 DRUG EFFECT INCOMPLETE 32
719 DRUG EFFECT PROLONGED 32
720 HEMIPLEGIA 32
721 INTERVERTEBRAL DISC DEGENERATION 32
722 INTRA-ABDOMINAL PRESSURE INCREASED 32
723 OROPHARYNGEAL DISCOMFORT 32
724 PERIPHERAL ISCHAEMIA 32
725 POLLAKIURIA 32
726 PRODUCT ADMINISTRATION ERROR 32
727 SCREAMING 32
728 STUPOR 32
729 SUBDURAL HAEMATOMA 32
730 SURGERY 32
731 VERTIGO 32
732 ADVERSE EVENT 31
733 ADVERSE REACTION 31
734 BACTERIAL INFECTION 31
735 CONVERSION DISORDER 31
736 DRY MOUTH 31
737 NEPHROLITHIASIS 31
738 NEPHROPATHY TOXIC 31
739 PANIC ATTACK 31
740 PHARMACEUTICAL PRODUCT COMPLAINT 31
741 SECRETION DISCHARGE 31
742 SUPERINFECTION 31
743 ANAL INCONTINENCE 30
744 ANTINUCLEAR ANTIBODY POSITIVE 30
745 ARTHROPATHY 30
746 BRADYPNOEA 30
747 CARDIAC DYSFUNCTION 30
748 DEAFNESS 30
749 DECUBITUS ULCER 30
750 DYSGEUSIA 30
751 GLOMERULAR FILTRATION RATE DECREASED 30
752 HEPATIC NECROSIS 30
753 HYPERAESTHESIA 30
754 HYPERPARATHYROIDISM SECONDARY 30
755 HYPERPYREXIA 30
756 IMPAIRED WORK ABILITY 30
757 INCONTINENCE 30
758 INJECTION SITE SWELLING 30
759 LYMPHOCYTE COUNT DECREASED 30
760 MYOGLOBINURIA 30
761 OSTEONECROSIS OF JAW 30
762 PAIN IN JAW 30
763 PHRENIC NERVE PARALYSIS 30
764 PRESCRIBED OVERDOSE 30
765 PUPIL FIXED 30
766 PUPILLARY REFLEX IMPAIRED 30
767 RASH PUSTULAR 30
768 RED BLOOD CELL COUNT DECREASED 30
769 RENAL FAILURE CHRONIC 30
770 RESPIRATORY ALKALOSIS 30
771 THROMBOPHLEBITIS 30
772 ACUTE LUNG INJURY 29
773 BLINDNESS 29
774 BRONCHOPULMONARY ASPERGILLOSIS 29
775 CROHN^S DISEASE 29
776 DEVICE RELATED INFECTION 29
777 ESCHERICHIA INFECTION 29
778 INTESTINAL PSEUDO-OBSTRUCTION 29
779 MALABSORPTION 29
780 MALIGNANT NEOPLASM PROGRESSION 29
781 MANIA 29
782 NERVE INJURY 29
783 ORGAN FAILURE 29
784 PNEUMATOSIS 29
785 PNEUMOCOCCAL SEPSIS 29
786 POISONING DELIBERATE 29
787 POOR QUALITY DRUG ADMINISTERED 29
788 QUADRIPARESIS 29
789 RIGHT VENTRICULAR FAILURE 29
790 SKIN LACERATION 29
791 SOPOR 29
792 VAGINAL HAEMORRHAGE 29
793 AMMONIA INCREASED 28
794 BREATH SOUNDS ABNORMAL 28
795 BURKHOLDERIA TEST POSITIVE 28
796 CONCOMITANT DISEASE AGGRAVATED 28
797 FEAR OF DEATH 28
798 FEELING COLD 28
799 FLUID RETENTION 28
800 HEPATORENAL FAILURE 28
801 HYDROCEPHALUS 28
802 IMPAIRED HEALING 28
803 LIVE BIRTH 28
804 LOWER RESPIRATORY TRACT INFECTION 28
805 METABOLIC ENCEPHALOPATHY 28
806 PCO2 DECREASED 28
807 PHARYNGEAL OEDEMA 28
808 PNEUMOMEDIASTINUM 28
809 PNEUMONIA STAPHYLOCOCCAL 28
810 POLYP 28
811 PSEUDOMONAL SEPSIS 28
812 RESTLESS LEGS SYNDROME 28
813 SKIN ULCER 28
814 SUSPECTED PRODUCT QUALITY ISSUE 28
815 TUMOUR LYSIS SYNDROME 28
816 ABDOMINAL COMPARTMENT SYNDROME 27
817 ACCIDENTAL EXPOSURE TO PRODUCT 27
818 CHOLECYSTITIS 27
819 CONJUNCTIVAL HYPERAEMIA 27
820 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 27
821 DRUG LEVEL CHANGED 27
822 ECONOMIC PROBLEM 27
823 EMOTIONAL DISORDER 27
824 FOETAL EXPOSURE DURING DELIVERY 27
825 HEART RATE IRREGULAR 27
826 HISTIOCYTOSIS HAEMATOPHAGIC 27
827 HYPOCAPNIA 27
828 IRON DEFICIENCY 27
829 MACROGLOSSIA 27
830 MONOPLEGIA 27
831 MYOCARDIAL INJURY 27
832 PHAEOCHROMOCYTOMA CRISIS 27
833 PREMATURE LABOUR 27
834 PUPILS UNEQUAL 27
835 RESPIRATION ABNORMAL 27
836 SENSORY DISTURBANCE 27
837 STOMATITIS 27
838 VASODILATATION 27
839 WOUND INFECTION 27
840 ANAESTHETIC COMPLICATION PULMONARY 26
841 BONE MARROW FAILURE 26
842 CARDIAC TAMPONADE 26
843 CHOREA 26
844 COMPARTMENT SYNDROME 26
845 DIASTOLIC DYSFUNCTION 26
846 ECZEMA 26
847 GUILLAIN-BARRE SYNDROME 26
848 HYPERTHYROIDISM 26
849 INCOHERENT 26
850 INSPIRATORY CAPACITY DECREASED 26
851 JOINT SWELLING 26
852 POST-TRAUMATIC STRESS DISORDER 26
853 RENAL CYST 26
854 SENSORY LOSS 26
855 SKIN LESION 26
856 SPINAL MUSCULAR ATROPHY 26
857 WOUND 26
858 WRONG DRUG ADMINISTERED 26
859 CEREBRAL HAEMATOMA 25
860 CONJUNCTIVITIS 25
861 CSF OLIGOCLONAL BAND PRESENT 25
862 CYST 25
863 DIVERTICULUM 25
864 ESCHERICHIA BACTERAEMIA 25
865 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 25
866 HOSPITALISATION 25
867 HYPOPNOEA 25
868 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 25
869 NEPHROPATHY 25
870 OBSTRUCTIVE SLEEP APNOEA SYNDROME 25
871 OPERATIVE HAEMORRHAGE 25
872 PERFORMANCE STATUS DECREASED 25
873 PETECHIAE 25
874 PLEOCYTOSIS 25
875 PO2 DECREASED 25
876 POSTOPERATIVE FEVER 25
877 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 25
878 RESPIRATORY TRACT INFECTION BACTERIAL 25
879 SCAR 25
880 SKIN REACTION 25
881 SPLENOMEGALY 25
882 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 25
883 ANGINA PECTORIS 24
884 BLOOD PHOSPHORUS INCREASED 24
885 BLOOD PRESSURE ABNORMAL 24
886 CARCINOID CRISIS 24
887 CONFUSION POSTOPERATIVE 24
888 CONTINUOUS HAEMODIAFILTRATION 24
889 EMBOLIC STROKE 24
890 ENTEROCOCCAL INFECTION 24
891 HEPATITIS TOXIC 24
892 HICCUPS 24
893 HYPORESPONSIVE TO STIMULI 24
894 IMPAIRED GASTRIC EMPTYING 24
895 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 24
896 LARGE INTESTINE PERFORATION 24
897 LEUKOENCEPHALOPATHY 24
898 MUSCLE TIGHTNESS 24
899 PERIORBITAL SWELLING 24
900 PLATELET COUNT INCREASED 24
901 PRINZMETAL ANGINA 24
902 QUADRIPLEGIA 24
903 SKIN DISORDER 24
904 TARDIVE DYSKINESIA 24
905 THROAT IRRITATION 24
906 TRACHEAL DEVIATION 24
907 UROSEPSIS 24
908 ANAL ABSCESS 23
909 BILIRUBIN CONJUGATED INCREASED 23
910 CLONIC CONVULSION 23
911 CONGESTIVE HEPATOPATHY 23
912 CREATININE RENAL CLEARANCE DECREASED 23
913 DIABETIC KETOACIDOSIS 23
914 DISTRIBUTIVE SHOCK 23
915 DRUG EFFECT LESS THAN EXPECTED 23
916 ENTEROCOLITIS 23
917 EXTRA DOSE ADMINISTERED 23
918 FAECES DISCOLOURED 23
919 HERPES ZOSTER 23
920 ILEUS PARALYTIC 23
921 INJECTION SITE REACTION 23
922 INTESTINAL OBSTRUCTION 23
923 ISCHAEMIA 23
924 LARYNGEAL STENOSIS 23
925 NEUTROPHIL COUNT INCREASED 23
926 OSTEOMYELITIS 23
927 OSTEOPOROSIS 23
928 PARKINSONISM 23
929 PHOTOPHOBIA 23
930 PRESYNCOPE 23
931 SYSTOLIC DYSFUNCTION 23
932 THYROTOXIC CRISIS 23
933 UNDERDOSE 23
934 WEIGHT BEARING DIFFICULTY 23
935 AORTIC VALVE INCOMPETENCE 22
936 APNOEIC ATTACK 22
937 BLINDNESS TRANSIENT 22
938 CELL DEATH 22
939 COLD SWEAT 22
940 DEMYELINATION 22
941 DEVICE MALFUNCTION 22
942 DRUG LEVEL DECREASED 22
943 ENCEPHALITIS AUTOIMMUNE 22
944 ENDOCARDITIS 22
945 FIBRIN D DIMER INCREASED 22
946 HEAD INJURY 22
947 HYPOACUSIS 22
948 ISCHAEMIC HEPATITIS 22
949 JOINT DISLOCATION 22
950 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 22
951 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 22
952 METABOLIC SYNDROME 22
953 OSTEOPENIA 22
954 RESPIRATORY TRACT INFECTION 22
955 ROAD TRAFFIC ACCIDENT 22
956 SERUM FERRITIN INCREASED 22
957 STAPHYLOCOCCAL SEPSIS 22
958 THERAPY CESSATION 22
959 TRANSFUSION 22
960 ABSCESS LIMB 21
961 ACCIDENTAL DEATH 21
962 ARTHRITIS 21
963 AZOTAEMIA 21
964 BLOOD AMYLASE INCREASED 21
965 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 21
966 BLOOD DISORDER 21
967 BLOOD PRESSURE DIASTOLIC DECREASED 21
968 BRONCHIAL DISORDER 21
969 CANDIDA INFECTION 21
970 CEREBRAL ATROPHY 21
971 CHOLECYSTITIS ACUTE 21
972 COORDINATION ABNORMAL 21
973 CYSTITIS 21
974 DEVICE DISLOCATION 21
975 DIVERTICULUM INTESTINAL 21
976 EYE PAIN 21
977 HEPATIC CONGESTION 21
978 INJECTION SITE ERYTHEMA 21
979 LANGUAGE DISORDER 21
980 LOCKED-IN SYNDROME 21
981 METASTASES TO BONE 21
982 MUSCLE CONTRACTIONS INVOLUNTARY 21
983 NEONATAL RESPIRATORY DEPRESSION 21
984 NEUROMYOPATHY 21
985 PERFORATION 21
986 PHYSICAL DISABILITY 21
987 PILOERECTION 21
988 PSEUDOCHOLINESTERASE DEFICIENCY 21
989 SMALL INTESTINAL OBSTRUCTION 21
990 SPINAL PAIN 21
991 STAPHYLOCOCCUS TEST POSITIVE 21
992 SUBSTANCE ABUSE 21
993 VOCAL CORD DYSFUNCTION 21
994 AIR EMBOLISM 20
995 ANTI FACTOR V ANTIBODY 20
996 BONE DISORDER 20
997 CHOLECYSTITIS CHRONIC 20
998 CLOSTRIDIUM TEST POSITIVE 20
999 DERMATITIS EXFOLIATIVE 20